Company archive
Read that company's published results in release order, newest first.
Showing 1-9 of 9 published briefings.
Headline result is distorted by portfolio divestments and a discontinued operation; operational EBITDAF rose only 7% to $514m and OCF fell 64.9%.
Published 21 April 2026
Read briefingThe June 2024 One NZ consolidation distorts headline comparability while proportionate EBITDAF of $986m sits near the top of $960–1,000m guidance.
Published 22 April 2026
Read briefingUnderlying proportionate EBITDAF rose 7%, while operating cash conversion fell from 41.6% to 18.4% as capex stepped up 25.9%.
Published 22 April 2026
Read briefingHeadline growth reflects a transformed asset base and a zero effective tax rate, while operating profit weakened and leverage stepped up sharply.
Published 22 April 2026
Read briefingContinuing-operations net parent surplus of NZ$1,215.1m and 45% Proportionate EBITDAF growth tell the real underlying story.
Published 22 April 2026
Read briefingPBT rose 53.2% and the margin was a record, but operating cash outflow widened to -NZ$234.6m and the lifted dividend is uncovered by cash.
Published 22 April 2026
Read briefingA NZ$1.1b after-tax gain from discontinued operations dominates headline NPAT, so PBT recovering from a NZ$91.8m loss is the cleaner operating read.
Published 22 April 2026
Read briefingThe 3,787.1% NPAT jump is a disposal accounting outcome, not an operating result, and FY22 Proportionate EBITDAF guidance was trimmed at the top end.
Published 22 April 2026
Read briefingThe NZ$350m acquisition price from the Pacific Radiology Group acquisition is result context, not the main operating signal.
Published 22 April 2026
Read briefingGet full NZX result briefings by email as new coverage is published.